Gráfico del Precio de Acciones HLOSF
HLOSF Dividendos
Healios K.K.
$1.8
0%
$0
Al cierre: Jun 18, 16:00:00 GMT-4
$1.8
0%
$0
Mercado Posterior: Jun 18, 20:00:00 GMT-4
Atrás
Healios K.K. (HLOSF) Dividendos
Estadísticas clave
Cierre Anterior
$1.8
Precio de apertura
$2.7
Rango del día
$1.8 - $2.7
Rango de 52 semanas
$1.8 - $4.45
Volumen
100
Volumen promedio
33
Rendimiento de dividendos
--
EPS (TTM)
-0.17
Cap. de mercado
$243.0M
¿Qué es HEALIOS K K?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 75 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Características
© 2026 Edgen impulsado por
